gliquidone has been researched along with Diabetic Nephropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Tian, H; Xie, Z; Yang, J | 1 |
| Chen, L; Cheng, LY; Jiang, YW; Ke, JT; Li, M; Lou, JN; Wu, W; Xu, SQ; Zhang, WJ | 1 |
| Gregorová, A; Rybka, J; Zmydlená, A | 1 |
| Hasslacher, C; Ritz, E | 1 |
4 other study(ies) available for gliquidone and Diabetic Nephropathies
| Article | Year |
|---|---|
Gliquidone Alleviates Diabetic Nephropathy by Inhibiting Notch/Snail Signaling Pathway.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Hypoglycemic Agents; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptors, Notch; Signal Transduction; Snail Family Transcription Factors; Sulfonylurea Compounds | 2018 |
Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats.
Topics: Absorption; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Kidney Tubules; Male; Proteinuria; Rats; Rats, Inbred Strains; Sulfonylurea Compounds | 2014 |
[Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Sulfonylurea Compounds | 1988 |
[Therapy of diabetic nephropathy].
Topics: Diabetic Nephropathies; Diet, Sodium-Restricted; Dietary Proteins; Humans; Hypertension; Insulin; Kidney Transplantation; Peritoneal Dialysis; Renal Dialysis; Sulfonylurea Compounds | 1985 |